Liver failure patients get two dialysis methods compared Head-to-Head
NCT ID NCT02310542
First seen Oct 01, 2025 · Last updated May 16, 2026 · Updated 32 times
Summary
This study compared two types of albumin dialysis (MARS and SPAD) in 34 people with severe liver failure. Both treatments filter toxins from the blood when the liver cannot. The goal was to see which one removes bilirubin better and is easier to use. Results help doctors choose the best option for supporting patients while they wait for their liver to recover or for a transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER FAILURE, ACUTE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital de la Croix Rousse - Service de réanimation chirurgicale
Lyon, 69317, France
Conditions
Explore the condition pages connected to this study.